Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of the U.S. economy, he would have to engage in the thorny challenges of governing.
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and changes in agency direction on issues like vaccines.
Marty Makary, Trump’s pick for FDA commissioner, testified before the Senate health committee Thursday.
A longtime Johns Hopkins surgeon and best-selling author, he has advised the World Health Organization and been elected to the National Academy of Medicine. (Makary, whose confirmation hearings kicked off in the Senate this morning,
At a hearing, Dr. Marty Makary, the nominee for F.D.A. commissioner, fielded questions focused on whether he would review or reopen certain policy areas.
Dr. Marty Makary, President Donald Trump’s pick to lead the FDA, sidestepped some questions through his confirmation hearing Thursday.
Questioned by senators at a Thursday hearing, President Trump's FDA nominee said he would reevaluate which scientific topics require an advisory committee's input.
President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators about how he would handle numerous pressing issues before the agency, including recent layoffs,
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback